MediSys Research Admin – Page 25 – Medisys Research

MediSys Research Admin

Author

MediSys Research Admin

Author

MediSys Research Admin Articles

Retained iatrogenic foreign body causing persistent non-healing wound: a case report

Retained iatrogenic foreign body causing persistent non-healing wound: a case report

August 18, 2020

Aisha Waquad, Hiren Patel, Mai Gandhi, Guny Gabriel

A rare case of an asymptomatic mesenteric hemangioma: an incidental finding

A rare case of an asymptomatic mesenteric hemangioma: an incidental finding

August 18, 2020

Stephanie A. Luster, Mai D. Gandhi, Michael R. Reich

A multidisciplinary approach to carotid body tumors surgical management

A multidisciplinary approach to carotid body tumors surgical management

August 18, 2020

David Fan,Stephanie Luster, Ibrahim G Eid, and Abdul Saied Calvino

Acute Generalized Exanthematous Pustulosis in an African American Male Caused by Trimethoprim-Sulfamethoxazole

Acute Generalized Exanthematous Pustulosis in an African American Male Caused by Trimethoprim-Sulfamethoxazole

August 10, 2020

Moshe Y. Bressler, Jeremy Minkowitz, Naeha Pathak, Andrew Mekaiel, Rebecca Tamez

Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study.

Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study.

Jiang C, Xie M, Cervellione K, Thurm C. Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study. BMC Res Notes. 2020;13(1):368. Published 2020 Aug 3. doi:10.1186/s13104-020-05210-2

A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.

A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.

Kinevant Sciences GmbH, KIN-1901-2001

A Contemporary Review of Radiation Pneumonitis

A Contemporary Review of Radiation Pneumonitis

Tofura Ullah , Harsh Patel , Grace M Pena , Rakesh Shah , Alan M Fein

Marked Elevation in Serum Procalcitonin Levels Do Not Correlate With Severity of Disease or Mortality in Hospitalized Patients: A Retrospective Study

Marked Elevation in Serum Procalcitonin Levels Do Not Correlate With Severity of Disease or Mortality in Hospitalized Patients: A Retrospective Study

Richard J Durrance, Tofura Ullah, Harsh Patel, Grace Martinez, Kelly Cervellione, Veronica B Zafonte, Khalid Gafoor, Farshad Bagheri

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)

$Rapidly progressive course of pauci-immune pulmonary capillaritis in a 70-year-old Asian male refractory to immunosuppression and plasma exchange$

Rapidly progressive course of pauci-immune pulmonary capillaritis in a 70-year-old Asian male refractory to immunosuppression and plasma exchange

Chuan Jiang, Grace Nabila Martinez Pena, Meng Xie2 and Khalid Gafoor